Republished: Value of biomarkers in osteoarthritis: current status and perspectives
…, JP Raynauld, S Reiter-Niesert… - Postgraduate …, 2014 - academic.oup.com
Osteoarthritis affects the whole joint structure with progressive changes in cartilage, menisci,
ligaments and subchondral bone, and synovial inflammation. Biomarkers are being …
ligaments and subchondral bone, and synovial inflammation. Biomarkers are being …
[HTML][HTML] Health economics in the field of osteoarthritis: an expert's consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and …
…, A Laslop, JP Pelletier, D Pinto, S Reiter-Niesert… - Seminars in arthritis and …, 2013 - Elsevier
Objectives There is an important need to evaluate therapeutic approaches for osteoarthritis
(OA) in terms of cost-effectiveness as well as efficacy. Methods The ESCEO expert working …
(OA) in terms of cost-effectiveness as well as efficacy. Methods The ESCEO expert working …
[HTML][HTML] Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopenia
…, BH Mitlak, A Pilotto, S Reiter-Niesert… - Aging clinical and …, 2016 - Springer
Purpose Sarcopenia is an age-related muscle condition which is frequently a precursor of
frailty, mobility disability and premature death. It has a high prevalence in older populations …
frailty, mobility disability and premature death. It has a high prevalence in older populations …
[HTML][HTML] Recommendations for an update of the 2010 European regulatory guideline on clinical investigation of medicinal products used in the treatment of …
JY Reginster, S Reiter-Niesert, O Bruyère… - Osteoarthritis and …, 2015 - Elsevier
Summary Objective The European Society on Clinical and Economic aspects of
Osteoporosis and Osteoarthritis (ESCEO) organised a working group to evaluate the need …
Osteoporosis and Osteoarthritis (ESCEO) organised a working group to evaluate the need …
[HTML][HTML] A reference case for economic evaluations in osteoarthritis: an expert consensus article from the European Society for Clinical and Economic Aspects of …
…, R Pinedo-Villanueva, D Pinto, S Reiter-Niesert… - Seminars in arthritis and …, 2014 - Elsevier
Background General recommendations for a reference case for economic studies in
rheumatic diseases were published in 2002 in an initiative to improve the comparability of …
rheumatic diseases were published in 2002 in an initiative to improve the comparability of …
[HTML][HTML] Can we identify patients with high risk of osteoarthritis progression who will respond to treatment? A focus on biomarkers and frailty
…, G Mautone, JP Pelletier, F Petit-Dop, S Reiter-Niesert… - Drugs & aging, 2015 - Springer
Osteoarthritis (OA), a disease affecting different patient phenotypes, appears as an optimal
candidate for personalized healthcare. The aim of the discussions of the European Society …
candidate for personalized healthcare. The aim of the discussions of the European Society …
DGRh recommendations for the implementation of current security aspects in the NSAID treatment of musculoskeletal pain
WW Bolten, K Krüger, S Reiter-Niesert… - Zeitschrift für …, 2016 - Springer
NSAIDs exert their anti-inflammatory and analgesic effects by inhibition of COX‑2, a key
enzyme for proinflammatory prostanoid synthesis. Therapy with NSAIDs is limited by their …
enzyme for proinflammatory prostanoid synthesis. Therapy with NSAIDs is limited by their …
[HTML][HTML] Short-term placebo response in trials of patients with symptomatic osteoarthritis: differences between hip and knee
S Reiter-Niesert, M Boers, J Detert - Osteoarthritis and cartilage, 2016 - Elsevier
Background In placebo-controlled RCT of symptomatic treatment in osteoarthritis (OA) the
extent of pain reduction is heterogeneous, the pooled effect size rather small. Pain reduction …
extent of pain reduction is heterogeneous, the pooled effect size rather small. Pain reduction …
DGRh-Empfehlungen zur Implementierung aktueller Sicherheitsaspekte in die NSAR-Therapie muskuloskelettaler Schmerzen
WW Bolten, K Krüger, S Reiter-Niesert… - Zeitschrift für …, 2016 - infona.pl
NSAR lindern Schmerz und Entzündung durch Hemmung der COX-2 und konsekutive
Verminderung der Synthese schmerzvermittelnder Prostaglandine. Unerwünschte …
Verminderung der Synthese schmerzvermittelnder Prostaglandine. Unerwünschte …
[CITATION][C] Recommendations for an update of the current (2010) European Regulatory Guideline on clinical investigation of medicinal products used in the treatment …
JY Reginster, S Reiter-Niesert, O Bruyère… - Osteoporosis …, 2015 - orbi.uliege.be
ORBi: Detailled Reference institution logo Login EN [EN] English [FR] Français logo Login EN
[EN] English [FR] Français Give us feedback Explore SearchSpecial collections Statistics News …
[EN] English [FR] Français Give us feedback Explore SearchSpecial collections Statistics News …